4D Molecular (FDMT) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Chardan Capital | Maintained | Buy | $25.00 from $26.00 | Oct 6, 2026 |
| B of A Securities | Maintained | Buy | $33.00 from $29.00 | Sep 29, 2026 |
| Cantor Fitzgerald | Upgraded | Neutral → Overweight | $20.00 | Sep 14, 2026 |
| B. Riley Securities | Initiated Coverage | Buy | $37.00 | Jul 31, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 | Jul 20, 2026 |
| Jefferies | Initiated Coverage | Buy | $21.00 from $40.00 | Mar 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 | Mar 20, 2026 |
| Chardan Capital | Maintained | Buy | $26.00 | Mar 19, 2026 |
| RBC Capital | Maintained | Outperform | $35.00 from $32.00 | Mar 19, 2026 |
| Barclays | Initiated Coverage | Overweight | $33.00 | Jan 28, 2026 |
| Chardan Capital | Maintained | Buy | $26.00 | Dec 18, 2025 |
| Chardan Capital | Maintained | Buy | $26.00 from $25.00 | Nov 11, 2025 |
| Barclays | Maintained | Overweight | $33.00 from $38.00 | Nov 11, 2025 |
| RBC Capital | Maintained | Outperform | $32.00 from $26.00 | Nov 11, 2025 |
| RBC Capital | Maintained | Outperform | $26.00 | Oct 21, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 | Aug 12, 2025 |
| Roth Capital | Maintained | Buy | $38.00 from $44.00 | Aug 12, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 | Aug 1, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 | Jul 3, 2025 |
| Barclays | Maintained | Overweight | $38.00 from $45.00 | May 9, 2025 |
Frequently asked questions
What is the price target for FDMT stock?
The average 12-month analyst price target for 4D Molecular (FDMT) is $30.20, with a high estimate of $37.00 and a low of $20.00, across 5 analysts.
Is FDMT a buy, sell, or hold?
Analysts covering 4D Molecular currently average a Buy rating: 11 buy, 1 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for FDMT?
The average price target of $30.20 implies 138.17% upside from the last price of $12.68.
What is the latest analyst rating on FDMT?
On Oct 6, 2026, Chardan Capital maintained 4D Molecular at Buy with a price target of $25.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.